Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who gave a written informed consent with complete understanding, after receiving a sufficient description of the study 2. Patients above the age of 20 up to 79 years when the consent is received 3. Patients meeting the criteria of 6.5% (NGSP) or more for HbA1c 4. Patients who are yet to start the therapy based on diabetes drugs, or those who are on oral drugs and insulin injections for diabetes, and the attending physician determines that there is almost no change in the HbA1c levels.(Almost no change observed in the status means that the maximum difference in HbA1c levels over a period of 3 months was less than 0.2 points.)
Exclusion criteria
Exclusion criteria: 1. Patients from whom consent cannot be obtained 2. Patients with type 1 diabetes 3. Patients with gestational diabetes 4. Diabetic retinopathy: Patients with proliferative retinopathy 5. Diabetic nephropathy: Patients with stage 3 or more 6. Patients determined by the doctor as having difficulty in filling the questionnaire
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference between the two groups for the change from baseline of the HbA1c levels at six months (plus or minus 1 month) from the first counseling session. | — |
Secondary
| Measure | Time frame |
|---|---|
| The changes from baseline for BMI, FBS, LDL, HDL, TG, SBP/DBP, dietary intake(energy, fat energy ratio etc), Change of health behavior and awarness | — |
Countries
Japan
Contacts
Nutrition Support Network LLC Research & Development Dept